Beverley Hunt

Beverley Jane Hunt FRCP, FRCPath, MD is professor of thrombosis & haemostasis at King's College, London,^[1] consultant in the departments of haematology, rheumatology^[2] and pathology^[3] and director of the Haemostasis Research Unit at Guy's and St Thomas' Foundation Trust, medical director of Lifeblood, the Thrombosis Charity and previous president of Walthamstow Hall Old Girls Association.^[4] She was educated at Walthamstow Hall^[5] and University of Liverpool.

Specialist interest and research

Professor Hunt is author and co-author of many peer-reviewed research articles. She has a specialist clinical and research interest in venous thromboembolism, thromboprophylaxis, antiphospholipid syndrome, lupus erythematosus, and obstetric haematology ^[6]

Books

She is co-editor of The Obstetric Hematology Manual,^[7] and also of An Introduction to Vascular Biology: From Basic Science to Clinical Practice ^[8]

Society memberships

She is the founder and co-lead of the British Society for Haematology Obstetric Haematology Group^[9] from 2004, a founder member of the society's Education Committee from 2009,^[10] and a member of the British Society for Haemostasis and Thrombosis,^[11] the International Society of Thrombosis and Haemostasis^[12] and is a Fellow of the Royal College of Physicians.

Contribution to national guidelines

She was the co-author of several reports and guidelines: the British Society of Haematology’s "Guidelines for TTP" in 2001 and 2002, and an advisor on the Royal College of Obstetricians and Gynaecologists: "Advice on preventing deep vein thrombosis for pregnant women travelling by air"^[13] produced in October 2001 and an advisor on the Royal College of Obstetricians guideline on: "Thromboprophylaxis in pregnancy"^[14] in 2004 and 2009.

She is a member of "The Independent Expert Panel on Venous Thromboembolism" 2005/6, and co-author on the "International Consensus report on the investigation and management of primary immune thrombocytopenia",^[15] the "Clinical guidelines for testing for heritable thrombophilia" ^[16] co-author on the "Guideline for investigation and management of adults and children presenting with a thrombocytosis" ^[17] the "Management of bleeding following major trauma: an updated European guideline".^[18]

She was a member of the National Institute for Health and Care Excellence (NICE) guidelines development group for: "reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital"^[19] published in 2010 and also the "Acute management of venous thromboembolism" published in 2012. On behalf of Lifeblood, the Thrombosis Charity, she was also a member of the committee producing the NICE Quality standards on VTE prevention.^[20]

Charity

Hunt is co-founder and Medical Director of Lifeblood, the Thrombosis Charity ^[21] which campaigns to raise awareness of thrombosis—in particular the risk of hospital-acquired deep vein thrombosis by mandating risk assessment.

Awards

She was winner in the Diagnostic/Laboratory category winner at the NHS London Innovation awards 2009 for “Detection of antiphospholipid antibodies based in heparin resistance.”,^[22] and won the 2011 Research paper of the year at the BMJ Group for a paper entitled "Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial" ^[23][24][25] which was published in the Lancet (2010;376:23-32).

References

External links

• GSTS
• Lifeblood, the Thrombosis Charity
• CRASH-2 Trial
• WOMAN Study